Nonalcoholic Steatohepatitis Not Yet Recruiting Phase 2 Trials for Digoxin (DB00390)

IndicationStatusPhase
DBCOND0029353 (Nonalcoholic Steatohepatitis)Not Yet Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT04216693Digoxin for Patients With Non-alcoholic Steatohepatitis (NASH)Treatment